Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

582.20 +1.63 (+0.28%)
Streaming Delayed Price Updated: 3:22 PM EST, Feb 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Analyst Expectations For Thermo Fisher Scientific's Future
Via Benzinga
Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per... 
Via StockStory
Topics Earnings
Exposures Financial
Top S&P500 movers in Thursday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday. 
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Smart Money Is Betting Big In TMO Options
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity For January 21
Via Benzinga
Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript
TMO earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beat
Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts. 
Via Investor's Business Daily
Thursday's session: gap up and gap down stock in the S&P500 index
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends. 
Via Chartmill
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased. 
Via Benzinga
Topics Earnings
Exposures Financial
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Thermo Fisher Scientific?
Via Benzinga
Check Out What Whales Are Doing With TMO
Via Benzinga
Earnings Scheduled For January 30, 2025
Via Benzinga
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI). 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely. 
Via Benzinga
Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch. 
Via MarketBeat
Market Whales and Their Recent Bets on TMO Options
Via Benzinga
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Via Benzinga
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
Exposures Product Safety
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Via Benzinga
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results. 
Via Benzinga
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test 
Via News Direct
The Oncology Bet Is Already Paying Off For Pfizer
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%... 
Via Benzinga
Exposures COVID-19
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening 
Via News Direct
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
Via Benzinga
Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.